Kymera Therapeutics, Inc. Share Price
KYMRKymera Therapeutics, Inc. Stock Performance
Open $79.95 | Prev. Close $80.80 | Circuit Range N/A |
Day Range $78.67 - $79.97 | Year Range $28.06 - $102.81 | Volume 8,279 |
Average Traded $79.42 |
Kymera Therapeutics, Inc. Share Price Chart
About Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa and atopic dermatitis. The company also develops STAT6, a type 2 inflammation in allergic and atopic diseases; and TYK2 to treat autoimmune and inflammatory diseases. The company has a strategic alliance with Sanofi S.A. for the development of drug candidates targeting IRAK4 outside of the oncology and immuno-oncology fields. Kymera Therapeutics, Inc. was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
Kymera Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
19-May-26 | $78.95 | $78.09 | -2.01% |
18-May-26 | $82.11 | $79.69 | -3.09% |
15-May-26 | $83.36 | $82.23 | -2.77% |
14-May-26 | $86.14 | $84.58 | -1.31% |
13-May-26 | $83.30 | $85.70 | +2.54% |
12-May-26 | $83.79 | $83.58 | -0.57% |
11-May-26 | $87.01 | $84.06 | -2.42% |
FAQs on Kymera Therapeutics, Inc. Share Price
Can I buy Kymera Therapeutics, Inc. shares in India?
What is the share price of Kymera Therapeutics, Inc.?
What is the 5 year returns of Kymera Therapeutics, Inc.?
What are the high & low stock price of Kymera Therapeutics, Inc. today?
What is the 52-week high and low of Kymera Therapeutics, Inc. stock?